Navigation Links
American Chemical Society's Weekly PressPac -- Sept. 10, 2008
Date:9/15/2008

ARTICLE #1 FOR IMMEDIATE RELEASE

Potential new drug for cocaine addiction and overdose
Journal of the American Chemical Society

Chemists are reporting development of what they term the most powerful substance ever discovered for eliminating cocaine from the body, an advance that could lead to the world's first effective medicine for fighting overdoses and addictions of the illicit drug. Their findings are scheduled for the Sept. 24 issue of the Journal of the American Chemical Society, a weekly publication.

In the new study, Chang-Guo Zhan and colleagues point out no effective anti-cocaine medication currently exists for cocaine abuse. One of the most promising approaches focuses on substances that mimic butyrylcholinesterase (BChE), a natural blood protein that helps break down and inactivate the drug, researchers say. However, natural BChE is too weak and ineffective for medical use, the researchers note.

The researchers describe design and produce the most potent, stable BChE structure ever produced. In lab studies, that form of BChE broke down, or metabolized, cocaine 2,000 times faster than the body's natural version of BChE, the scientists say, noting that reducing levels of the drug in the blood is a key to fighting overdose in humans. The substance also prevented convulsions and death when injected into mice that were given overdoses of cocaine, they note. MTS

ARTICLE #1 FOR IMMEDIATE RELEASE
"Most Efficient Cocaine Hydrolase Designed by Virtual Screening of Transition States"

DOWNLOAD FULL TEXT ARTICLE
http://dx.doi.org/10.1021/ja803646t

CONTACT:
Chang-Guo Zhan, Ph.D.
University of Kentucky
Lexington, Kentucky 40536
Phone: 859-323-3943
Fax: 859-323-3575
Email: zhan@uky.edu


ARTICLE #2 FOR IMMEDIATE RELEASE


'/>"/>
Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert  

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. New gene variant identified for nondiabetic end stage renal disease in African-Americans
2. Silent streams? Escalating endangerment for North American freshwater fish
3. American Chemical Societys Weekly PressPac -- Sept. 3, 2008
4. African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease
5. NYU, American Museum of Natural History receive $1.6 million NSF grant
6. American Chemical Societys Weekly PressPac -- Aug. 27, 2008
7. Highlights from the September 2008 Journal of the American Dietetic Association
8. Gene therapy anti-cancer research featured in Scientific American
9. American Chemical Societys Weekly PressPac -- Aug. 13, 2008
10. American Chemical Societys Weekly PressPac -- Aug. 6, 2008
11. Study helps pinpoint genetic variations in European Americans
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
American Chemical Society's Weekly PressPac -- Sept. 10, 2008
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... announced today that it will report financial results for ... 23, 2015, after the close of market. The company ... investors at 2:00 p.m. PT (5:00 p.m. ET), during ... To participate on the live call, analysts and investors ...
(Date:4/2/2015)... , April 2, 2015 ... Q1 2015 attributed to somewhat higher than 125 MSEK. ... the year-end report 2014 that revenues for Q1 2015 ... the company reported for Q4 2014. The operating result ... be negative. The complete interim report will as previously ...
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... CA -- Li Qian, PhD, has won the Louis ... for Young Investigators from the American Heart Association (AHA), ... that a Gladstone Institutes researcher has been the recipient. ... Gladstone -- a leading and independent biomedical-research organization -- ...
... 2011   Life Technologies Corporation (NASDAQ: ... company has introduced its GeneArt® Algae Engineering Kits, ... systems for photosynthetic microalgae Chlamydomonas reinhardtii ... model organisms for the study of photosynthesis, circadian ...
... is available in French . , MONTREAL, November ... a leukemic relapse in young patients is a step closer ... and the University of Montreal. Approximately 20 percent of young ... umbilical cord blood will experience leukemic relapse. The researchers, findings, ...
Cached Biology News:Gladstone scientist receives American Heart Association's Katz prize for cardiovascular research 2GeneArt® Algae Engineering Kits by Life Technologies™ 2GeneArt® Algae Engineering Kits by Life Technologies™ 3New hope for young leukemia patients? 2
(Date:5/6/2015)... CA (PRWEB) May 06, 2015 ... today announced NX-Hivac, the only high vacuum AFM system ... needs for failure analysis semiconductor manufacturing. Park NX-Hivac is ... in failure analysis solutions in highly doped semiconductor processing ... required. , The high vacuum scanning spreading resistance ...
(Date:5/6/2015)... , May 6, 2015 Dr Jaspreet ... Massey University, will deliver a speech at the 2015 Asian ... the Shanghai New Expo Center.  ... introduce to attendees the topic: ,Potato Starch: A Potential ... Smart Foods., Co-editor of a 528 page ...
(Date:5/5/2015)... , May 5, 2015  Blueprint Medicines ... of its initial public offering of 9,367,708 shares ... of $18.00 per share, including shares of common ... underwriters of their option to purchase additional shares. ... to Blueprint Medicines were approximately $168.6 million, before underwriting ...
(Date:5/5/2015)... 5, 2015  23andMe, Inc., the leading personal genetics ... Research Study in collaboration with Pfizer Inc. The ... erythematosus, more commonly known as lupus, into the study ... effort is also in collaboration with the Lupus Research ... May. Approximately 1.5 million people in the ...
Breaking Biology Technology:Park Systems Introduces Park NX-Hivac, a High Vacuum SSRM AFM System for Optimal Results in Semiconductor Manufacturing Failure Analysis 2Park Systems Introduces Park NX-Hivac, a High Vacuum SSRM AFM System for Optimal Results in Semiconductor Manufacturing Failure Analysis 3Potato Starch: A Potential Source for the Creation of Next Generation Bulk-ingredients and Smart Foods 2Blueprint Medicines Announces Closing of Initial Public Offering 223andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc. 223andMe Launches the Lupus Research Study in Collaboration with Pfizer Inc. 3
... 31, 2012  bioTheranostics, Inc., a bioMerieux company that ... treatment, has introduced a new product line of ... pathway interrogation called PRECIS Precision Medicine by bioTheranostics(SM). ... partners accurate diagnosis of primary tumor site and ...
... rap music can be harnessed to power a new type ... body. Acoustic waves from music, particularly rap, were found ... ultimately help to treat people stricken with aneurisms or incontinence ... a vibrating cantilever, a thin beam attached at one end ...
... The technique builds on previous research in which microbubbles were ... produce an oil which can be processed to create a ... important alternative to fossil fuels and algae, in particular, has ... now, however, there has been no cost-effective method of harvesting ...
Cached Biology Technology:bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation 2bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation 3Rap music powers rhythmic action of medical sensor 2Rap music powers rhythmic action of medical sensor 3Microbubbles provide new boost for biofuel production 2
Yields DNA greater than 50 kb in length from yeast, fungi, Gram neg. and Gram pos. bacteria...
Anti-human L-Ficolin, Clone GN4, Monoclonal Antibody...
B3GALT2 Immunogen: B3GALT2 (NP_003774, 324 a.a. ~ 423 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... Rabbit polyclonal to ThPok ( Abpromise for ... Synthetic peptide conjugated to KLH derived from within ... (Note: the amino acid sequence is proprietary) ... .) Entrez Gene ID: ...
Biology Products: